Skip to main content

Advertisement

Log in

Production and characterization of an anti-(MUC1 mucin) recombinant diabody

  • ORIGINAL ARTICLE
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

A recombinant diabody fragment based on the anti-MUC1 monoclonal antibody, C595 has been produced in a bacterial expression system. Substitution of a 7-amino-acid linker sequence (Gly6Ser) for the original single-chain (sc)Fv 15-amino-acid linker (Gly4Ser)3, using polymerase-chain-reaction-based strategies, forces variable heavy (VH) and light (VL) domains to pair with complementary domains on neighbouring scFv molecules, forming a scFv dimer (diabody). This recombinant protein shows similar binding characteristics to the parental C595 monoclonal antibody. The ability to bind to MUC1 mucin on carcinoma cell surfaces will allow its potential as a diagnostic and therapeutic reagent of clinical utility to be investigated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 16 September 1998 / Accepted: 2 December 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Denton, G., Brady, K., Lo, B. et al. Production and characterization of an anti-(MUC1 mucin) recombinant diabody. Cancer Immunol Immunother 48, 29–38 (1999). https://doi.org/10.1007/s002620050545

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002620050545

Navigation